Unibest

Pharmaceutical intermediates

Quizartinib Intermediates

3 pharmaceutical intermediates for Quizartinib. Indication: Acute myeloid leukemia; Myeloid leukemia.

提交项目All intermediates

About Quizartinib

Originator
Ambit Biosciences Co
Indication
Acute myeloid leukemia; Myeloid leukemia
Approved Date
07/20/2023
NCE Patent
07/20/2028
DS/DP
03/16/2027

Available intermediates

3 intermediates currently listed for Quizartinib. Request specifications, documentation or a quotation for any item below.

Quizartinib intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(5-tert-butyl-isoxazol-3-yl)-carbaMic acid phenyl ester81479-48-3//
4-(2-Chloroethyl)morpholine hydrochloride3647-69-6//
3-Amino-5-tert-butylisoxazole55809-36-4//

Building toward Quizartinib?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →